Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio? - Boston Scientific (NYSE:BSX), IQVIA Hldgs (NYSE:IQV), IREN (NASDA

Group 1 - PayPal Holdings, Inc. (NASDAQ: PYPL) experienced a significant decline of 22.92% after reporting worse-than-expected fourth-quarter financial results and appointing Enrique Lore as CEO [1] - Multiple analysts have lowered their price forecasts for PayPal's stock following the disappointing results [1] Group 2 - Novo Nordisk (NYSE: NVO) saw a decrease of 17.75% after announcing its fourth-quarter financial results, which included a forecast for a decline in FY26 adjusted sales guidance [2] - Hims & Hers Health Inc. (NYSE: HIMS) is expanding its weight loss specialty by allowing providers to prescribe a Compounded Semaglutide Pill, which contains the same active ingredient as Novo Nordisk's Wegovy [2]